GAL4ϾUAS-PAR-1 flies exhibited a mild rough eye and loss of photoreceptor neuron phenotype (Figures 1H While analyzing the neuronal function of PAR-1, we found that Drosophila PAR-1 is a physiological kinase and 1J). To further address the cell type specificity and to distinguish between neurodevelopmental or neurodefor fly tau and h-tau. Overexpression of PAR-1 leads to elevated tau phosphorylation and enhanced toxicity, generative mechanisms of PAR-1-induced toxicity, we used a heat shock-GAL4 driver to direct PAR-1 overexwhereas removing PAR-1 function or mutating PAR-1 phosphorylation sites in tau abolishes tau toxicity. Furpression. Induction of ubiquitous PAR-1 overexpression by daily heat shock treatment starting from first instar thermore, we have uncovered an initiator role for PAR-1 in a multisite phosphorylation process that generates larval stage resulted in animals with rough eyes and accompanying photoreceptor loss ( Figures 1K and 1N ). pathogenic forms of tau. In this process, phosphorylation by PAR-1 precedes and is obligatory for downThe animals are otherwise normal externally. Heat shock induction starting from pupae or young adult stages, stream phosphorylation events, including those carried out by GSK-3 and Cdk5, to generate toxic tau. Consiswhen photoreceptor neurons are fully differentiated, also resulted in a photoreceptor loss phenotype (Figures tent with PAR-1 playing an initiator role in the process, mutating PAR-1 phosphorylation sites causes a much 1L, 1O, and 1P). Together, these results indicate that PAR-1 overexpression-induced toxicity is relatively spemore dramatic reduction of overall tau phosphorylation and toxicity than mutating one of the downstream Cdk5/ cific to photoreceptor neurons and that this toxicity is mediated at least in part through a progressive degener-GSK-3 phosphorylation sites. These findings have important implications for understanding the biogenesis ation mechanism. of pathogenic tau in neurons and for developing mechanism-based therapeutic strategies.
Genetic Interaction between PAR-1 and Tau
The degeneration phenotype induced by PAR-1 overexpression could be mediated by abnormal phosphorylaResults tion of its substrate(s) the relationship between tau and PAR-1 in the process. A fly tau homolog was recently shown to be expressed pression of PAR-1 to photoreceptor neurons using the sevenless-GAL4 line resulted in eye degeneration in in the nervous system (Heidary and Fortini, 2001), but no information on its loss-of-function or overexpression newly emerged adult flies. Strong PAR-1 expression lines exhibited severely reduced eyes, with fused ommaphenotype is available. We used a chromosomal deficiency associated with Tp(3;Y)R97 to test possible getidia and missing inter-ommatidial bristles, as revealed by scanning electron microscopy (SEM) analysis (Figure netic interaction between endogenous fly tau and PAR-1. Through single embryo PCR analysis, we con-1C). Weak or mild expression lines had slightly reduced eyes, which appeared rough and had disordered ommafirmed that this deficiency deletes fly tau. In flies overexpressing the strong PAR-1 transgene and heterozygous tidia and occasional missing bristles ( Figure 1B) . However, in flies that express two copies of the weak PAR-1 for the chromosomal deficiency, the eye degeneration phenotype was partially suppressed ( Figure 2B ). This transgene, the eye degeneration phenotype became more severe, similar to that observed in the strong exsuggests that endogenous fly tau may mediate PAR-1-induced eye degeneration phenotype. pression line (data not shown). Thus, overexpression of PAR-1 using the sevenless-GAL4 driver causes eye We next tested for possible genetic interaction between fly PAR-1 and h-tau. Overexpression of the four degeneration in a dosage-dependent manner. No effect was observed when PAR-1 KN, which contains an inacti-C-terminal tandem repeats (4R) isoform of h-tau containing the R406W mutation (henceforth referred to as vating point mutation in the kinase domain, was expressed under sevenless-GAL4 control ( Figure 1D ). This h-tauM), which is associated with a familial form of FTDP-17 (Hutton et al., 1998; Wittmann et al., 2001), indicates that the kinase activity of PAR-1 is required for inducing the eye degeneration phenotype. caused a moderate eye degeneration phenotype ( Figure  2C ). Coexpression of the weak PAR-1 transgene, which Staining of eye sections revealed that loss of photoreceptor neurons is associated with the eye degeneration by itself had a small effect on eye morphology ( Figure  1B ), enhanced h-tauM toxicity and resulted in smaller phenotype ( Figures 1E and 1F) . Since sevenless-GAL4 is expressed in the early developing eye disc and is later sized eyes ( Figure 2D ). The effect of the genetic interaction is also reflected by the extent of photoreceptor expressed in photoreceptor neurons as well as nonneuronal pigment and cone cells, the loss of photoreneuron loss. As shown in Figure 2G , PAR-1 and h-tauM coexpressing flies showed a greater neuronal loss (15%, ceptor neuron phenotype could be due to progressive neurodegeneration or developmental perturbation of n ϭ 1050, 5 samples) than files expressing h-tauM (6%, Figure 3A) . Flies expressing h-tauM alone also exhibited strong staining dues between h-tau and fly tau suggests that 12E8 may also recognize phosphorylated fly tau. Indeed, a basal with 12E8, albeit at a lower level ( Figure 3B ). This was confirmed by Western blot analysis ( Figure 3E) . To estilevel of 12E8 staining was detected in wild-type flies ( Figure 3D ). In flies that overexpress PAR-1, the level of mate the level of h-tauM phosphorylation at S262/S356 sites, we used 12E8 antibody-immunoprecipitated 12E8 staining was significantly elevated ( Figure 3C ). This was also confirmed by Western blot analysis ( Figure 3E ). PAR-1, these GST-tau fusion proteins did not react with 12E8. Immunoreaction with 12E8 was readily detected Thus, overexpression of PAR-1 can lead to elevated phosphorylation of both h-tauM and fly tau at the two after incubation with PAR-1 ( Figure 3F ). When the kinase-negative form of PAR-1 (PAR-1 KN) was used in Ser residues recognized by 12E8.
t test. (H and I) Tau immunostainings of transgenic brain expressing h-tau (H) or coexpressing h-tau and PAR-1 (I). Arrows in (I) indicate vacuoles within the processes of the giant interneuron commissure. (J-L) SEM of transgenics expressing wild-type h-tau (J), PAR-1 (K), or h-tau and PAR-1 (L). (M and N) AT100 immunostaining of transgenic fly brain coexpressing PAR-1 and h-tauM (M) or Shaggy and h-tauM (N). Sevenless-GAL4 driver was used in (A)-(F), (J)-(L), and (N), Cha-GAL4 was used in (H), (I), and (M).

MT binding domain of h-tau (Seubert et al., 1995). Bioh-tauM as standard in
To test whether PAR-1 directly phosphorylates tau at the assay, 12E8 immunoreactivity was barely detectable ( Figure 3G ). Together, these experiments demonstrate these sites, we performed in vitro kinase assays using purified PAR-1 and bacterially expressed recombinant that PAR-1 directly phosphorylates h-tau and fly tau to generate pS262 and pS356 residues recognized by glutathione-S-transferase (GST) fusion proteins of wildtype h-tau and fly tau. Without preincubation with 12E8. ., 2000) . The h-tauM transgene was uniformly expressed in these eyes under sevenless-GAL4 1999). We tested whether these sites in h-tauM were also phosphorylated by the corresponding fly kinases. control. On average, more than half of the mosaic eye were composed of homozygous par-1 mutant clones.
The activity of Cdk5 is regulated by its binding with neuron-specific activators. Overexpression of DrosophWestern blot analysis on single fly heads indicated that h-tauM phosphorylation at 12E8, AT8, and AT100 epiila P35 activator has been shown to elevate endogenous Cdk5 activity (Connell-Crowley et al., 2000) . In P35 and tope sites was significantly reduced in par-1 Ϫ/Ϫ mosaic eyes compared to par-1 ϩ/ϩ eyes ( Figure 5I ). Together h-tauM coexpression flies, we observed that the level of phosphorylation at S202 recognized by CP13 antibody is with the Western blot analysis of S2A transgenic flies, these data suggest that phosphorylation by PAR-1 at elevated. In addition, phosphorylation at AT270 sites was also significantly increased. Phosphorylation at S262 and S356 is a prerequisite for the subsequent phosphorylation by other kinases in a temporally or-AT100, AT180, and PHF-1 sites was relatively unchanged ( Figure 6D ). Thus, phosphorylation at S202 and T181 dered phosphorylation process. responds to changes in Cdk5 levels. The eye morphol-PHF-1, CP13, AT180, and AT100 sites ( Figure 6D ). We conclude that these phospho-epitopes contain GSK-3 ogy of P35 and h-tauM coexpressing flies appeared similar to that of flies expressing h-tauM alone (Figures phosphorylation sites and that elevated phosphorylation at these sites enhances tau toxicity. 6A and 6B), suggesting that elevated Cdk5 activity does not significantly enhance tau toxicity. We next analyzed
The fact that many of the above-tested phosphorylation sites for GSK-3 and Cdk5 kinases are affected in Shaggy and h-tauM coexpression flies. As reported previously (Jackson et al., 2002) , coexpression of Shaggy S2A suggests that phosphorylation by the two kinases is regulated by prior PAR-1 action. To test this idea and h-tau resulted in enhanced eye degeneration phenotypes ( Figure 6C ). In the coexpression flies, we obfurther, we analyzed the phosphorylation status of GSK-3 and Cdk5 phosphorylation sites in PAR-1 and served significantly increased tau phosphorylation at h-tauM coexpression flies. In addition to 12E8 sites, significant increase of phosphorylation was observed at CP13 and PHF-1 sites in these flies ( Figure 6D ). In contrast, phosphorylation at other sites such as AT100 sites was little changed, suggesting that PAR-1 is not a rate-limiting factor for these phosphorylation events. Since in vitro kinase assays showed that PAR-1 is incapable of directly phosphorylating the CP13 and PHF-1 sites (data not shown), the elevated phosphorylation at these sites in PAR-1 coexpressing flies are likely mediated by downstream kinases such as Cdk5 and GSK-3.
We further tested whether coexpression of PAR-1, GSK-3, or Cdk5 has any modulating effect on S2A toxicity in vivo. PAR-1 and S2A coexpression flies showed a mild rough eye phenotype similar to PAR-1 overexpression alone ( Figure 6E, compare to Figure 1B) , indicating that PAR-1 overexpression does not confer additional toxicity to S2A. Cooverexpression of GSK-3 or Cdk-5 also did not change S2A toxicity (Figures 6F and  6G) . These results further support the notion that phos- 
Phosphorylation Site (S202A) Has Much Smaller
Sevenless-GAL4 driver was used in all panels.
Effects on Overall tau Phosphorylation and Toxicity than S2A Mutations
Since the S2A mutation disrupts tau phosphorylation erative diseases are still poorly defined. Studying these at multiple downstream sites, it does not allow us to diseases in model organisms offers the power of genetic distinguish the contribution of individual phosphorylaanalysis to dissect the disease processes. In this study, tion sites to tau toxicity. We wished to address this we have shown that PAR-1, the fly homolog of mammaissue by making point mutations in the downstream lian MARK kinase, plays a central role in conferring tau phosphorylation sites. We focused on the S202 site betoxicity in vivo. Our study reveals PAR-1 function in cause it is phosphorylated by Cdk5 and GSK-3 in vivo triggering a temporally ordered phosphorylation proand because AT8 antibody, which is sensitive to phoscess that is responsible for generating toxic forms of phorylation at this site, was considered an Alzheimertau. This multisite phosphorylation process involves diagnostic antibody. We generated transgenic flies that downstream kinases such as Cdk5 and GSK-3, whose express h-tauM containing an Ala substitution at S202 action depends on prior phosphorylation of h-tau by (S202A). Western blot analysis demonstrated that, as PAR-1. A nonphosphorylatable mutation at S202, one predicted, S202A protein was no longer recognized by of the downstream GSK-3/Cdk5 target sites whose CP13 or AT8 antibodies. Significantly, phosphorylation phosphorylation depends on prior PAR-1 action, has a at 12E8, AT100, PHF-1, AT180, and AT270 sites was much smaller impact on overall tau phosphorylation and unaffected by S202A mutation ( Figure 7E ). This suggests toxicity than mutations at PAR-1 phosphorylating sites. 
